The purpose of this study is to compare patient comorbidity profiles and their genomics medicine guided drug selections. Comorbidity refers to the presence of more than one disease or health condition in a patient at the same time. Genomics medicine involves using information about a person's genes to guide treatment decisions. This study aims to see if these data can improve the current strategy for selecting precision medicine drugs.

Participants in the study will have their comorbidity profiles and genomics information analyzed. The study will track the side effects experienced by participants to assess the effectiveness of the genomics-guided drug selections. This approach may help refine how precision medicine drugs are chosen for different patients.

• Who can participate: Eligibility criteria include adults aged 18 and over, with specific comorbid conditions relevant to the study's focus. Further key eligibility factors will be provided during the screening process.
• Study details: Participants will undergo analysis of their comorbidity profiles and genomics information to guide drug selection. The study will monitor side effects to evaluate the effectiveness of these selections.